Sageworth Trust CO Edwards Lifesciences Corp Transaction History

Sageworth Trust CO

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 08, 2023	BUY	$74.26 - $84.51 $16,114 - $18,338	217 New	217 $17,000
Q3 2020 Nov 04, 2020	SELL	$67.19 - $87.44 $201 - $262	-3 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$57.54 - $76.95 $172 - $230	3 New	3 $0
Q2 2019 Jul 19, 2019	SELL	$55.74 - $64.41 $891 - $1,030	-16 Closed	0 $0
Q1 2019 Apr 08, 2019	BUY	$47.89 - $64.05 $574 - $768	12 Added 300.0%	16 $3,000
Q4 2018 Jan 18, 2019	BUY	$46.41 - $56.94 $185 - $227	4 New	4 $1,000
Q2 2018 Jul 19, 2018	SELL	$42.45 - $51.3 $3,183 - $3,847	-75 Closed	0 $0
Q1 2018 May 03, 2018	BUY	$37.19 - $47.45 $2,789 - $3,558	75 New	75 $10,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Sageworth Trust CO, based on Form 13F filings with the SEC.

Stay updated on Sageworth Trust CO with notifications on news.